Alliance for Clinical Trials in Oncology

Clinical Trials

Browse or search Alliance’s portfolio of active and completed trials in oncology. Visit ClinicalTrials.gov for contact information, full trial details, eligibility criteria, and how to enroll.

Search by keyword, trial ID, or study chair

Disease/Cancer Type

Alliance Committee

Status

Trial Type

Alliance Committee
Trial Title
Study ID
Disease/Cancer Type
Status
Study Chair Name
Breast Cancer
Celecoxib in Treating Women With Metastatic or Recurrent Breast Cancer
NCT00045591
Breast Cancer
Closed
Charles L. Shapiro, MD
Genitourinary Cancer
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
NCT00002889
Prostate Cancer
Closed
Anthony V. D’Amico, MD, PhD
Respiratory Cancer
Video-Assisted Surgery Followed by Radiation Therapy in Treating Patients With Stage I Non-small Cell Lung Cancer and Poor Heart and Lung Function
NCT00002624
Lung Cancer & Mesothelioma
Closed
Hani Shennib, MD
Study of Aerosolized Sargramostim in Treating Patients With Melanoma Metastatic to the Lung
NCT00005610
Melanoma & Skin Cancers
Closed
Svetomir Markovic, MD, PhD
Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
NCT00080951
Colorectal / Colon / Rectal Cancer
Closed
Charles Erlichman, MD
Cancer Control
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma
NCT01781468
Brain / Central Nervous System Cancer
Closed
Alyx B. Porter Umphrey, MD
Pentostatin in Treating Patients With Refractory Chronic Graft-Versus-Host Disease
NCT00074035
Other Cancer
Closed
Sherif S. Farag, MD, PhD
Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer
NCT00006349
Lung Cancer & Mesothelioma
Closed
Aminah Jatoi, MD
Respiratory Cancer
Optimal Sequencing of Pembrolizumab (MK-3475) and Standard Platinum-based Chemotherapy in First-Line NSCLC
NCT02591615
Lung Cancer & Mesothelioma
Closed
Thomas Hensing, MD
Leukemia
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
NCT07321652
Leukemia & Myelodysplastic Syndromes (MDS)
Open
Jennifer R Brown, MD

Research in Action

See how Alliance trials are advancing treatment

Alliance News